Did you know that peripheral arterial disease (PAD) is asymptomatic in 50-75% of cases(1)? This is an alarming statistic, especially when we consider that PAD is a strong risk factor for cardiovascular disease (the leading cause of death worldwide).
Considering also that 25% of cases of sudden cardiac death have no prior symptoms or appreciable risk factors(2), the need for early detection of PAD becomes clear.
As well as its link to mortality, PAD is a leading cause of morbidity - PAD can lead to foot ulceration, which can lead to amputation - with devastating physical and emotional impacts on the individual as well as significant financial implications for the health system.
Currently, PAD is underdiagnosed, hence undertreated(3). There is a compelling need for more targeted screening in at-risk populations to reduce morbidity and mortality rates in people with PAD.
One of the reasons for underdiagnosis is inadequate screening due to a lack of knowledge among Health Professionals of which assessments are most effective in making a diagnosis of PAD. Commonly used tests for PAD have limited sensitivity in the most at-risk populations (4). Clinical assessments range from simple observation to more complex ABI (ankle-brachial index). Research supports the use of some, but not all of these assessment techniques. Below are some of the most common:
Another barrier to effective screening is that certain guidelines don’t reflect the latest evidence.
With all this in mind, I’m sure you’re keen to learn more. Join us on Monday, August 6th at 7.30PM (AEST) for a one-hour webinar, where our expert presenter Dr Sylvia McAra will share a best-practice approach to assessing PAD using evidence-based clinical tests.
This is a multidisciplinary webinar for Podiatrist, GPs and Nurses. Click here to read more and enrol.
References:
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreToday, Medcast launched a new Australian AI-led healthcare technology platform, giving doctors and health organisations instant access to contextual answers from trusted clinical knowledge sources while earning Continuing Professional Development (CPD) as they work.
A/Prof Debra Kennedy from Mothersafe provides GPs with expert guidance on safely managing medications in the preconception and antenatal periods, offering practical advice to support patients throughout pregnancy.
Tailored health assessments for Aboriginal and Torres Strait Islander patients may be billed under MBS item number 715. This FastTrack details the eligibility criteria, related services, and additional considerations for First Nations health assessment to support sustainable, culturally-safe care. 30mins each RP and EA CPD available.